Aberrant Expression TFR1/CD71 in Gastric Cancer Identifies a Novel Potential Prognostic Marker and Therapeutic Target.

Jielu CaoCan HuJingli XuJing HanRuolan Zhang Mengxuan Cao Li Yuan Zhi-Yuan Xu

Published in: Evidence-based complementary and alternative medicine : eCAM (2022)

TFR1 was overexpressed in GC and its aberrant expression identifies a novel potential prognostic marker and therapeutic target. In addition, TFR1 expression may be associated with the immune microenvironment and suppress the immune response via regulating the PD-L1 expression.

Keyphrases

poor prognosis
immune response
genome wide
binding protein
gene expression
dna methylation
toll like receptor
human health
high resolution
gas chromatography